Candorium Free Members
Join Candorium to access the full article and more
Free Member Benefits:
✔
Comment & Reply✔
Newsletter Access✔
Follow Authors✔
Share via SMS Go Back
EyePoint Pharmaceuticals: Q2 Earnings Snapshot
By AP News - Aug 07, 2024, 07:09 AM ET
Last Updated - Aug 07, 2024, 07:09 AM EDT
WATERTOWN, Mass. (AP) — WATERTOWN, Mass. (AP) — EyePoint Pharmaceuticals (EYPT) on Wednesday reported a loss of $30.8 million in its second quarter.
On a per-share basis, the Watertown, Massachusetts-based company said it had a loss of 58 cents.
Sponsored
The results did not meet Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 55 cents per share.
The drug delivery technology company posted revenue of $9.5 million in the period, which also missed Street forecasts. Three analysts surveyed by Zacks expected $11.6 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on EYPT at https://www.zacks.com/ap/EYPT
Sponsored
Read More from Investing
Popular News
Latest News
